EIDY: Motor Parameters in Patients With Limb Girdle Muscular Dystrophy

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Recruiting
CT.gov ID
NCT04772027
Collaborator
(none)
80
1
45
1.8

Study Details

Study Description

Brief Summary

The primary objective of the study is to perform 2-year follow up with motor parameters evolution using instrumental assessments in patients with limb girdle muscular dystrophie, and to identify which motor parameters are sensitive to change.

The secondary objectives of the study are:
  • to describe the changes of the parameters obtained from instrumental evaluations in comparison with the changes obtained from clinical assessments.

  • to characterize the muscular impairments, the biomechanical gait disorders, the standing postural control disorders, the biomechanical upper limb disorders in spatial exploration, the limitation of upper limb capacities, the fatigue, the endurance, the patients' participation to their activities and their quality of life, in comparison with a healthy paired population.

  • to highlight the relationships between muscular assessment parameters, biomechanical gait parameters, standing posture control and upper limb spatial exploration.

  • to highlight the relationships between data from instrumental assessments and data from clinical assessments.

  • to highlight the relationships between instrumental assessments data and clinical assessments data on one side, and features of patients (age, sex, duration since diagnosis, type of LGMD, rehabilitation in follow-up, sportive practices...) on the other side.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a monocentric study in which 2 sub-groups of people will be enrolled: LGMD patients and healthy volunteers. Each enrolled LGMD patient will have 5 visits during 2 years, one baseline visit and four half-yearly visits. Each enrolled healthy volunteer will have one planned visit only. The duration of enrollments will last 20 months.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    80 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Characterization and Identification of Motor Parameters Using Instrumental Assessment in Patients With Limb Girdle Muscular Dystrophy
    Actual Study Start Date :
    Apr 1, 2021
    Anticipated Primary Completion Date :
    Jan 1, 2025
    Anticipated Study Completion Date :
    Jan 1, 2025

    Arms and Interventions

    Arm Intervention/Treatment
    Muscular dystrophies group

    40 patients with limb girdle muscular dystrophie

    Comparator group

    40 healthy volunteers without neuromuscular or squeletic disorder

    Outcome Measures

    Primary Outcome Measures

    1. Change from baseline on maximal strength [Assessed at 6 months, 12 months, 18 months and 24 months]

      Maximal strength and muscular activation of knee extensors will be evaluated by isometric test with an isokinetic dynamometer (Biodex Medical Systems Inc., Shirley, New York, USA).

    2. Change from baseline on peak hip flexion [Assessed at 6 months, 12 months, 18 months and 24 months]

      Hip flexion peak during gait will be evaluated with tridimensional gait analysis with an optoelectronic system ((Optitrack system, Natural Point Inc. Corvallis, OR, USA)

    3. Change from baseline on speed of center of pression during standing postural control [Assessed at 6 months, 12 months, 18 months and 24 months]

      Speed of center of pression will be measured by force platforms (AMTI, Advanced Mechanical Technology).

    4. Change from baseline on elbow peak extension during upper limb spatial exploration [Assessed at 6 months, 12 months, 18 months and 24 months]

      Elbow peak extension will be measured biomechanically with an optoelectronic system during upper limb spatial exploration (Optitrack system, Natural Point Inc. Corvallis, OR, USA)

    Secondary Outcome Measures

    1. Change from baseline on muscular parameters [Assessed at 6 months, 12 months, 18 months and 24 months]

      Maximal strength during isometric tests of hip, knee flexors, ankle and maximal grip strength. (Biodex Medical Systems Inc., Shirley, New York, USA) Muscular fatigue

    2. Joint kinematic parameters: change from baseline on gait speed [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used. Spatio-temporal = speed (m/s)

    3. Joint kinematic parameters: change from baseline on step length [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    4. Joint kinematic parameters: change from baseline on cadence [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    5. Joint kinematic parameters: change from baseline on step width [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    6. Joint kinematic parameters: change from baseline on % single support phase of gait cycle [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    7. Joint kinematic parameters: change from baseline on % swing phase of gait cycle [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    8. Joint kinematic parameters: change from baseline on % support phase of gait cycle [Assessed at 6 months, 12 months, 18 months and 24 months]

      Spatio-temporal from biomechanical gait analysis: an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) will be used.

    9. Change from baseline on kinetic gait parameters [Assessed at 6 months, 12 months, 18 months and 24 months]

      Kinetic parameters will be obtained from biomechanical gait analysis with AMTI force plateforms (Advanced Mechanical Technology, Waterton, MA, USA). This includes peak of ground reaction force in antero-posterior and vertical axis.

    10. Change from baseline on standing postural control parameters: COP displacements [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include: Mean and maximal speed of center of pression (COP) displacements.

    11. Change from baseline on standing postural control parameters: elliptic surface [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include: Elliptic surface covering 90% of COP positions.

    12. Change from baseline on standing postural control parameters: Amplitude of COP [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include: Amplitude of COP shift in anteroposterior and mediolateral axis.

    13. Change from baseline on standing postural control parameters: Romberg quotient [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). Parameters of stabilization include: Romberg quotient.

    14. Change from baseline on standing postural orientation parameters [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). The orientation parameters include: mean position of COP in anteroposterior and mediolateral axis.

    15. Change from baseline on standing postural orientation parameters: limb loading ratio [Assessed at 6 months, 12 months, 18 months and 24 months]

      Parameters of stabilization and postural orientation during postural control assessment on force platforms (AMTI, Advanced Mechanical Technology), Waterton, MA, USA). The orientation parameters include: limb loading ratio.

    16. Change from baseline on drinking task with left and right upper limb: velocity and movement time [Assessed at 6 months, 12 months, 18 months and 24 months]

      The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including: Velocity and movement time (Total movement time / Peak velocity/ Mean velocity)

    17. Change from baseline on drinking task with left and right upper limb: movement strategy [Assessed at 6 months, 12 months, 18 months and 24 months]

      The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including: Movement strategy (Time to peak velocity / time to first peak)

    18. Change from baseline on drinking task with left and right upper limb: smoothness and coordination movement [Assessed at 6 months, 12 months, 18 months and 24 months]

      The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including: Smoothness and coordination movement (number of movements units / interjoint coordination)

    19. Change from baseline on drinking task with left and right upper limb: trunk displacement [Assessed at 6 months, 12 months, 18 months and 24 months]

      The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including: Trunk displacement

    20. Change from baseline on drinking task with left and right upper limb: angular joint [Assessed at 6 months, 12 months, 18 months and 24 months]

      The spatio-temporal parameters will be obtained from biomechanical analysis with an optoelectronic system (Optitrack system, Natural Point Inc. Corvallis, OR, USA) including: Angular joint

    21. Change from baseline on 6 minutes walking test distance [Assessed at 6 months, 12 months, 18 months and 24 months]

      6 minutes walking test

    22. Change from baseline on the Berg Balance Scale score [Assessed at 6 months, 12 months, 18 months and 24 months]

      The Berg Balance Scale

    23. Change from baseline on Brooke Upper Extremity Scale score [Assessed at 6 months, 12 months, 18 months and 24 months]

      Brooke Upper Extremity Scale score for upper extremity capacities.

    24. Change from baseline on locomotor [Assessed at 6 months, 12 months, 18 months and 24 months]

      Questionnaires Abiloco

    25. Change from baseline on upper limb capacities [Assessed at 6 months, 12 months, 18 months and 24 months]

      Questionnaires Abilhand

    26. Change from baseline on patient occupations [Assessed at 6 months, 12 months, 18 months and 24 months]

      Patient occupations assessed by COPM (Canadian Occupational Performance Measure). The measurement will be from 1 (not at all performant) to 10 (very performant) as score.

    27. Change from baseline on MRC (Medical Research Council) score on flexors and extensors of lower and upper limb [Assessed at 6 months, 12 months, 18 months and 24 months]

      Testing MRC (Medical Research Council), a scale for muscle power. The muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle.

    28. Change from baseline on Fatigue Severity Scale (FSS) score [Assessed at 6 months, 12 months, 18 months and 24 months]

      Questionnaire Fatigue Severity Scale (FSS) for fatigue assessment

    29. Change from baseline on number of fall risks [Assessed at 6 months, 12 months, 18 months and 24 months]

    30. Change from baseline on number of physiotherapy sessions per week [at baseline, 6 months, 12 months, 18 months and 24 months]

    31. Change from baseline on number of sports practice per week [at baseline, 6 months, 12 months, 18 months and 24 months]

    32. Change from baseline on Individualized Neuromuscular Quality of Life Questionnaire (INQoL) [Assessed at 6 months, 12 months, 18 months and 24 months]

      Quality of life questionnaire: INQoL

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • For limb girdle muscular dystrophie group:

    • Patients diagnosed limb girdle muscular dystrophie;

    • Aged between 18 and 70 years;

    • Covered by the French social security scheme;

    • Patient able to maintain upright position alone;

    • Able to walk at least 10 meters and 6 minutes consecutively without help.

    • For Volunteer group:

    • Adult (18 to 70 years) without neuromuscular or squeletic disorder.

    Exclusion Criteria:

    § For all:

    • Without associated neuromuscular disorders such as respiratory or muscular-squeletic diseases, apart from the consequences of dystrophy;

    • Contraindication to the tests;

    • Noncontrol cardiac rhythm disorders;

    • Lying down position intolerance due to severe respiratory troubles;

    • Pregnant or breastfeeding woman.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Laboratoire d'analyse du mouvement, Service d'exploration fonctionnelles, Hôpital Raymond Poincaré, APHP Garche France 92380

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Céline BONNYAUD, PhD, Laboratoire d'analyse du mouvement, Service d'explorations fonctionnelles, Hôpital Raymond Poincaré, APHP
    • Study Director: Samuel POUPLIN, Plateforme Nouvelles Technologies, Hôpital Raymond Poincaré, APHP

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT04772027
    Other Study ID Numbers:
    • APHP200141
    • 2020-A02090-39
    First Posted:
    Feb 25, 2021
    Last Update Posted:
    May 3, 2022
    Last Verified:
    Apr 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Assistance Publique - Hôpitaux de Paris
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 3, 2022